AGE-RELATED BONE LOSS

Clinical trials for AGE-RELATED BONE LOSS explained in plain language.

Never miss a new study

Get alerted when new AGE-RELATED BONE LOSS trials appear

Sign up with your email to follow new studies for AGE-RELATED BONE LOSS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Scientists test 'Senolytic' drugs to fight bone aging

Disease control Ongoing

This study is testing whether two different drug combinations can safely slow down bone loss in older adults with osteoporosis or osteopenia. Researchers are comparing a 'senolytic' drug pair (dasatinib and quercetin) taken in cycles, a daily antioxidant (nicotinamide riboside), …

Matched conditions: AGE-RELATED BONE LOSS

Phase: PHASE2 • Sponsor: Odense University Hospital • Aim: Disease control

Last updated Mar 18, 2026 14:41 UTC

AGE-RELATED BONE LOSS

Get alerted when new AGE-RELATED BONE LOSS trials appear

Scientists test 'Senolytic' drugs to fight bone aging